---
template: report
version: 1.0
feature: medication-interactions
date: 2026-06-15
author: benhwang121@gmail.com
project: Supplement Stack Intelligence Platform
version_project: 0.1.0
milestone: v2
cycle_number: 4
---

# medication-interactions Completion Report

> **Project**: Supplement Stack Intelligence Platform
> **Version**: 0.1.0 → v2
> **Author**: benhwang121@gmail.com
> **Completion Date**: 2026-06-15
> **PDCA Cycle**: #4 (first v2 feature)

---

## Executive Summary

### 1.1 Project Overview

| | |
|--|--|
| Feature | medication-interactions |
| Start Date | 2026-06-15 |
| End Date | 2026-06-15 |
| Duration | 1 session (Plan→Design→Do×2→Check→Act-1→QA→Report) |
| Method | Plan Plus + PDCA, Architecture Option C (pragmatic) |

### 1.2 Results Summary

| Metric | Result |
|--------|--------|
| Match Rate | **99%** (runtime-verified) |
| Success Criteria | **6/6 met** |
| Unit tests | 87/87 green (47 pre-existing + 40 incl. 18 new interaction + others) |
| Runtime | L1 (3) + L2 (2) green on live server; L3 authed gated by `E2E_LIVE` |
| Build / Types | `next build` green (15 SSG pages), `tsc --noEmit` clean |
| QA Gate | **QA_PASS** |

### 1.3 Value Delivered

| Perspective | Content |
|-------------|---------|
| **Problem** | v1's medication-conflict detection was a placeholder (`MED_CAUTION_IDS` set + generic copy); the highest-trust safety question — "does this supplement clash with my drugs?" — went unanswered. |
| **Solution** | A pure, deterministic `lib/interactions` engine + curated `seed-interactions`/`medication-aliases` datasets that normalize meds (brand→generic→drug-class), match supplement↔drug and supplement↔supplement rules, grade severity, and route all copy through `lib/safety`. |
| **Function/UX Effect** | Real findings now surface under "Interaction Risk" in Stack Evaluation (with a critical-severity clinician-escalation banner), demote/flag conflicting Protocol Builder suggestions, and render an "Interactions" section + honest empty state on every Library page. Verified live: fish-oil shows anticoagulant interaction; creatine shows "No known interactions in our dataset"; evaluate route enforces 401. |
| **Core Value** | The safety pillar moved from aspirational to real — the single highest-trust v2 upgrade — with zero external licensing, full editorial control of wording, and no loss of determinism. |

---

## 1.4 Success Criteria Final Status

| # | Criterion | Status | Evidence |
|---|-----------|:------:|----------|
| SC-1 | Detect supp↔drug-class interactions | ✅ Met | `lib/interactions/index.ts:findInteractions`; unit + live L2 (fish-oil↔anticoagulant) |
| SC-2 | Med normalization (brand→generic→class) | ✅ Met | `normalize.ts`; test "Coumadin→warfarin→anticoagulant" |
| SC-3 | Supp↔supp interactions | ✅ Met | pair loop in `findInteractions`; test "magnesium↔zinc" |
| SC-4 | Surface in Eval + Protocol + Library | ✅ Met | `ruleInteractions`, engine-backed `hasMedicationCaution`, `InteractionSection` (live-rendered) |
| SC-5 | Safety wording + high-sev escalation | ✅ Met | all copy via `lib/safety`; `StackWorkspace` critical banner + `DISCLAIMERS.interaction` |
| SC-6 | Pure / deterministic / unit-tested | ✅ Met | 18 L0 tests incl. determinism + banned-language sweep; 87/87 suite |

**Success Rate: 6/6 (100%).**

---

## 1.5 Decision Record Summary

| Source | Decision | Followed | Outcome |
|--------|----------|:--------:|---------|
| [Plan] | Approach A — curated-seed engine (no external API) | ✅ | Trust + determinism; no licensing dependency. A→external upgrade path preserved (pure module). |
| [Plan] | Anchor on medication-interaction layer | ✅ | Highest-trust v2 capability delivered. |
| [Design] | Architecture C — pure module + thin finding→flag mapper, 3 surfaces | ✅ | One engine feeds evaluator/protocol/library; reused existing flag UI. |
| [Design] | Seed-as-code, no DB table/RLS | ✅ | Reference data in `src/data`; zero migration. |
| [Design] | Warn, never hard-block | ✅ | Findings inform; no add-blocking introduced. |
| [Design] | Drug-warning → critical escalation | ✅ | `to-flags.ts:mapSeverity`; banner fires on critical. |

---

## 2. Related Documents

| Phase | Document | Status |
|-------|----------|--------|
| Plan | [medication-interactions.plan.md](../01-plan/features/medication-interactions.plan.md) | ✅ Finalized |
| Design | [medication-interactions.design.md](../02-design/features/medication-interactions.design.md) | ✅ Finalized |
| Check | [medication-interactions.analysis.md](../03-analysis/medication-interactions.analysis.md) | ✅ Complete (99%) |
| QA | [medication-interactions.qa-report.md](../05-qa/medication-interactions.qa-report.md) | ✅ QA_PASS |

---

## 3. Completed Items

### 3.1 Functional Requirements

| # | Requirement | Status |
|---|-------------|:------:|
| FR-1 | `findInteractions({medications, stackItems}) → InteractionFinding[]` | ✅ |
| FR-2 | Medication normalization w/ graceful unresolved handling | ✅ |
| FR-3 | Drug-class + exact-generic matching | ✅ |
| FR-4 | Supplement↔supplement detection | ✅ |
| FR-5 | Severity + mechanism + management + evidence per finding | ✅ |
| FR-6 | Safety-framed copy + high-severity escalation | ✅ |
| FR-7 | Findings merged into Stack Evaluation ("Interaction Risk") | ✅ |
| FR-8 | Protocol Builder flags/demotes conflicting suggestions | ✅ |
| FR-9 | Library page renders all rules for a supplement | ✅ |
| FR-10 | No finding implies "safe" (honest empty state) | ✅ (live-verified) |

### 3.2 Non-Functional Requirements

| # | Requirement | Status |
|---|-------------|:------:|
| NFR-1 | Pure, deterministic, DB-agnostic engine | ✅ |
| NFR-2 | Tests green; tsc clean; build green; no regression | ✅ (87/87, 15 SSG pages) |
| NFR-3 | Zod-validated typed dataset | ✅ |
| NFR-4 | Safety/compliance language rules upheld | ✅ (banned-language sweep) |

### 3.3 Deliverables

| Type | Location | Status |
|------|----------|:------:|
| Domain types | `src/types/interaction.ts` | ✅ |
| Engine | `src/lib/interactions/{index,normalize,to-flags,schema,medication-names}.ts` | ✅ |
| Datasets | `src/data/{seed-interactions,medication-aliases}.ts` | ✅ |
| Safety copy | `src/lib/safety/index.ts` | ✅ |
| Evaluator wiring | `src/lib/stack-evaluator/rules.ts` | ✅ |
| Protocol wiring | `src/lib/protocol-builder/rules.ts` | ✅ |
| UI | `components/library/InteractionSection.tsx`, `StackWorkspace.tsx`, `ProfileForm.tsx`, `ui/TagInput.tsx` | ✅ |
| Tests | `lib/interactions/interactions.test.ts`, `tests/e2e/medication-interactions.spec.ts` | ✅ |

---

## 4. Incomplete Items

### 4.1 Carried Over

| Item | Reason | Target |
|------|--------|--------|
| Run L3 authed e2e (escalation-banner flow) under `E2E_LIVE=1` | No demo creds in this environment | When Supabase demo user is seeded |
| Design §5.4 wording: header "(hidden if zero)" | Intentionally always-shown per FR-10 | Doc cleanup |

### 4.2 Deferred (v3, per Plan §3.2)

External interaction API/RxNorm, supplement↔condition & pregnancy rules, persisted dismissals, admin CMS.

---

## 5. Quality Metrics

### 5.1 Final Analysis

| Axis | Rate |
|------|:----:|
| Structural | 100% |
| Functional | 100% (post Act-1) |
| Contract | 100% |
| **Overall** | **99% (runtime-verified)** |

### 5.2 Resolved Issues

| ID | Issue | Resolution |
|----|-------|-----------|
| IMP-1 | Unrecognized-medication note not surfaced | Act-1: `ruleInteractions` emits an info flag per unresolved med via `safetyCopy.unrecognizedMedication()` + test |
| QA test-precision | fish-oil assertion matched 2 elements | Scoped to section row heading; implementation unchanged |

---

## 6. Lessons Learned & Retrospective

### 6.1 What Went Well (Keep)
- Reusing v1's pure-engine pattern made the new engine drop-in: same `DraftFlag` shape meant **zero new flag UI**.
- The Plan's curation-honesty risk was encoded as an executable **banned-language sweep** test — caught nothing because the design held, but it's now a permanent guardrail.
- Two-module Do split (engine → surfaces) kept each session focused and independently verifiable.
- A live dev server upgraded verification from v1's "static-only" to **runtime-verified** for the public surfaces.

### 6.2 What Needs Improvement (Problem)
- The unrecognized-med note (IMP-1) was specced in Design §5.4 but missed in Do — a Design checklist item slipped between "engine" and "surface" modules. Tighter Do-phase checklist mapping would have caught it before Check.
- E2E assertions were written without accounting for pre-existing page copy (the anticoagulant collision), surfacing only at QA.

### 6.3 What to Try Next (Try)
- Seed the demo Supabase user so the authed L3 escalation flow can be part of standard QA, not gated.
- When curating safety datasets, pair each rule with its provenance note for future clinical review (a step toward the deferred condition/pregnancy rules).

---

## 7. Next Steps

- `/pdca archive medication-interactions` — archive to `docs/archive/2026-06/medication-interactions/` (matches v1 features).
- Optional: `/simplify` for a cleanup pass before archive.

---

## Version History
| Version | Date | Changes | Author |
|---------|------|---------|--------|
| 1.0 | 2026-06-15 | Completion report — 99% runtime-verified, QA_PASS, SC 6/6 | benhwang121@gmail.com |
